Solara Active Pharma Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Solara Active Pharma Sciences has a total shareholder equity of ₹10.9B and total debt of ₹8.2B, which brings its debt-to-equity ratio to 75.3%. Its total assets and total liabilities are ₹22.9B and ₹12.0B respectively.
Key information
75.3%
Debt to equity ratio
₹8.20b
Debt
| Interest coverage ratio | n/a |
| Cash | ₹60.70m |
| Equity | ₹10.89b |
| Total liabilities | ₹12.01b |
| Total assets | ₹22.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 541540's short term assets (₹7.6B) do not cover its short term liabilities (₹10.5B).
Long Term Liabilities: 541540's short term assets (₹7.6B) exceed its long term liabilities (₹1.5B).
Debt to Equity History and Analysis
Debt Level: 541540's net debt to equity ratio (74.7%) is considered high.
Reducing Debt: 541540's debt to equity ratio has increased from 58.2% to 75.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 541540 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 541540 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 4.7% per year.